👀 Ones to watch: The MOST undervalued shares to buy right nowSee Undervalued Shares

Australia shares fall as tech weighs, Melbourne extends lockdown

Published 07/09/2020, 11:25 am
Updated 07/09/2020, 11:30 am
© Reuters.
AXJO
-
CSL
-
CBA
-
AZN
-
WBC
-
AXFJ
-
AXIJ
-
IXIC
-
NZ50
-
XRO
-
APT
-

* Tech rout continues, sub-index hits over 3-week low

* CSL signs agreements for potential COVID-19 vaccines

* Melbourne lockdown extended to late Sept.

Sept 7 (Reuters) - Australian shares fell nearly a percent on Monday, following the previous session's sell-off, after technology shares fell tracking their Wall Street peers on Friday and as Melbourne extended a coronavirus-led lockdown till late September.

The S&P/ASX 200 index .AXJO fell 0.9% to 5,869.9 points by 0030 GMT on Monday, after it lost 3.1% in the previous session.

Technology stocks .AXIJ , the biggest percentage losers, fell 2.4% to hit their lowest level in more than three weeks.

Their losses follow the tech-heavy Nasdaq index's .IXIC 1.3% fall on Friday after investors dumped heavyweight technology stocks due to concerns about high valuations. .N

Compounding worries of an economic recovery, the hot spot state of Victoria on Sunday extended a hard lockdown in Australia's second largest city due to a slower than hoped decline in its infection rate. which now accounts for about 75% of the country's total infections of 26,282, reported 63 new cases and five more deaths on Sunday.

Among tech firms, the biggest decliners were buy now pay later firm Afterpay Ltd APT.AX down 4% and software firm Xero Ltd XRO.AX lost 2.3%.

Heavyweight financials .AXFJ , down 1%, weighed the most on the index, with top lenders Commonwealth Bank of Australia CBA.AX and Westpac Banking Corp WBC.AX falling 1% and 0.4%, respectively.

In a bright spot, CSL CSL.AX rose 2.8% after the heavyweight biotech firm said it signed an agreement with the Australian government to produce an AstraZeneca AZN.L and Oxford University COVID-19 vaccine candidate. also signed an agreement with the government to supply 51 million doses of an alternative potential vaccine it is developing with the University of Queensland.

In New Zealand, the benchmark S&P/NZX 50 index .NZ50 swung between gains and losses. It was down 0.1% by 0049 GMT, with financials dragging the index.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.